Tag Archives: Intermune

December 01 2013 – Human stem cells converted to functional lung cells

NEW YORK, NY — For the first time, scientists have succeeded in transforming human stem cells into functional lung and airway cells. The advance, reported by Columbia University Medical Center (CUMC) researchers, has significant potential for modeling lung disease, screening … Continue reading

Posted in Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, IPF, Long Fibrose, Longfibrose, Lung Cancer, Lungen Fibrose, Medical | Tagged , , , , , , , , , , , , , , , , , , | Leave a comment

November 30 2013 – Keyhole lung transplant performed on 60-year-old in Chennai

Surgeons at Global Health City have performed a minimally-invasive lung transplant on a 60-year-old patient, who has been suffering from idiopathic pulmonary fibrosis for the last 11 years. The lung transplant was done through a seven-inch-long incision, which is nearly … Continue reading

Posted in Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, IPF, Long Fibrose, Longfibrose, Lung Cancer, Lungen Fibrose, Medical | Tagged , , , , , , , , , , , , , , , | Leave a comment

November 15 2013 – Enzo Biochem Announces Study in Leading Scientific Journal Linking Idiopathic Pulmonary Fibrosis, a Deadly Human Disease with No Effective Treatment Options, to Presence of a Monkey Virus

Enzo Biochem Inc. (NYSE:ENZ) today announced publication of a study in a leading scientific journal Modern Pathology a Nature Publishing Group publication that shows a strong association of idiopathic pulmonary fibrosis (IPF) a pulmonary disease with 100% mortality within five … Continue reading

Posted in Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, IPF, Long Fibrose, Longfibrose, Lung Cancer, Lungen Fibrose, Medical | Tagged , , , , , , , , , , , , , , , , | Leave a comment

November 4 2013 – Development Plan for PTL-202, a Treatment for Progressive Organ Scarring, a $1.1 Billion Opportunity

Worldwide, there are over 5,000,000 people living with Idiopathic Pulmonary Fibrosis (IPF)(IPF Coalition).IPF therapy sales across the US, France, Germany, Italy, Spain, and the UK to rise to over $1.1 billion by 2017, at a Compound Annual Growth Rate (CAGR) … Continue reading

Posted in Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, IPF, Long Fibrose, Longfibrose, Lung Cancer, Lungen Fibrose, Medical | Tagged , , , , , , , , , , , , , , , , , | Leave a comment

October 28 2013 – Ambrisentan (Letairis) stopped early in IPF trial (Annals Int Med)

Ambrisentan (Letairis) stopped early in IPF trial A large phase III randomized trial testing Ambrisentan (Letairis) for early idiopathic pulmonary fibrosis was stopped early after an interim analysis of the data showed possible harm. The results were reported in Annals of … Continue reading

Posted in Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, IPF, Long Fibrose, Longfibrose, Lung Cancer, Lungen Fibrose, Medical, Pulmonary Fibrosis | Tagged , , , , , , , , , , , , , , , , , | Leave a comment

October 18 2013 – UW researchers to test novel therapy for idiopathic pulmonary fibrosis

Dear Colleagues: I am very pleased to report that UW researchers have received a grant from the National Institutes of Health (NIH) to test a promising, novel surgical therapy for treating idiopathic pulmonary fibrosis (IPF). IPF is a chronic, progressive … Continue reading

Posted in Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, IPF, Long Fibrose, Lung Cancer, Lungen Fibrose, Medical, Pulmonary Fibrosis, Uncategorized | Tagged , , , , , , , , , , , , , , , , | Leave a comment

October 11 2013 – UAB gets $9.7 million to find treatments for deadly lung disease pulmonary fibrosis

UAB gets $9.7 million to find treatments for deadly lung disease pulmonary fibrosis by Bob Shepard Grant will allow UAB researchers to study novel therapies for pulmonary fibrosis, a deadly lung disease with no approved treatments. The University of Alabama at … Continue reading

Posted in Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, IPF, Long Fibrose, Lung Cancer, Lungen Fibrose, Medical, Pulmonary Fibrosis, Uncategorized | Tagged , , , , , , , , , , , , , , , , , , | Leave a comment

October 10 2013 – Finding cellular causes of lung-hardening disease

Medical Xpress)—Idiopathic Pulmonary Fibrosis, or IPF, is an incurable lung disease that, over time, turns healthy lung tissue into inflexible scar tissue – hardening the lungs and eventually causing respiratory distress and death. Currently, there is no cure. Phil Sannes, … Continue reading

Posted in Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, IPF, Long Fibrose, Lungen Fibrose, Medical, Pulmonary Fibrosis, Uncategorized | Tagged , , , , , , , , , , , , , , , , | Leave a comment

October 9 2013- Promedior Initiates Phase 2 Clinical Study of PRM-151 in Myelofibrosis

Promedior, Inc., a clinical stage biotechnology company developing novel biologic therapeutics for the treatment of fibrosis, announced today that it has initiated a Phase 2 clinical trial to evaluate PRM-151, its lead product candidate, in patients with myelofibrosis. Promedior is … Continue reading

Posted in Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, IPF, Long Fibrose, Lung Cancer, Lungen Fibrose, Medical, Pulmonary Fibrosis, Uncategorized | Tagged , , , , , , , , , , , , , , , , , , | 1 Comment

October 3 2013 – Newly identified biomarkers help predict outcome in deadly lung disease

New Haven, Conn. – A Yale-led study has identified a gene expression profile that can predict outcomes and lead to better treatment for one of the most lethal lung diseases, idiopathic pulmonary fibrosis (IPF). The study appears in Science Translational … Continue reading

Posted in Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, IPF, Long Fibrose, Lung Cancer, Lungen Fibrose, Medical, Pulmonary Fibrosis, Uncategorized | Tagged , , , , , , , , , , , , , , , , , | Leave a comment